marijuana stocks news

Form 8-K for CARA THERAPEUTICS, INC.


11-Jan-2016

Regulation FD Disclosure, Financial Statements and Exhibits

Item 7.01. Regulation FD Disclosure.A copy of the investor presentation that Cara Therapeutics, Inc. plans to use in conjunction with meetings, beginning on January 11, 2016, during the J.P. Morgan Healthcare Conference is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference. The information contained in the presentation furnished as Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or the Exchange Act, and is not incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in any such filing.

 

Item 9.01. Financial Statements and Exhibits.(d) Exhibits

Exhibit
No. Description

99.1 Cara Therapeutics, Inc. Corporate Presentation January, 2016.

 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Innocan Pharma Corporation (INNPF) Announces Closing of Private Placement

Innocan Pharma Announces Closing of Private Placement Innocan Pharma Corporation (CSE: INNO)…

$OGRMF Gives Shareholder Update

Organigram Provides Shareholder Update MONCTON, NEW BRUNSWICK–(Marketwired – Jan 20, 2015) –…

 Leafbuyer Technologies, Inc. (LBUY) Reports Substantial Growth in Oklahoma

Leafbuyer Technologies, Inc. Reports Substantial Growth in Oklahoma  Leafbuyer Technologies, Inc. (“Leafbuyer” or…

MediPharm Labs Corp. (MEDIF) (LABS) and Cronos Group Enter Private Label Contract Manufacturing Agreement

MediPharm Labs and Cronos Group Enter Private Label Contract Manufacturing Agreement MediPharm…